Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 203 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
203
Total Funding
$3.7B
Avg Funding
$148.5M
Cities
21

Export 203 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Waltham, United States
$30.0M
raised

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States

Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, Canada
$4.3M
raised

Indiva provide access to medical cannabis.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Watertown, United States
$45.0M
raised

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$90.0M
raised

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$50.0M
raised

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$1.2B
raised

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$1.6M
raised

PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$566K
raised

SOL is an international cannabis company that offers strategic investments and partnerships.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Burlingame, United States
$201.0M
raised

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Richmond, United States
$115.0M
raised

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Matawan, United States
$100.0M
raised

Apimeds Pharmaceuticals is a company that develops therapeutic application solutions for honeybee venom used for inflammatory conditions.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$350.0M
raised

Belite Bio is a clinical stage biopharmaceutical drug development company.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$550.0M
raised

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$99.2M
raised

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Naarden, The Netherlands
$452.6M
raised

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cranbury, United States
$165.0M
raised

Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Tórtola, Spain
$1.3M
raised

CRISM Therapeutics is a pharmaceutical company that develops ChemoSeed to improve the clinical performance of cancer treatments.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Burlington, Canada
$966K
raised

Rapid Dose Therapeutics is a Pharma-Tech Company that brings drug delivery solutions to a new level.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$2.5M
raised

NetraMark is an AI and pharma-tech company, has developed proprietary solutions for pharmaceutical and biotechnology companies.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Fort Worth, United States
$100.0M
raised

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$20.3M
raised

Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

West Chester, United States
$50.0M
raised

Verrica Pharmaceuticals is an innovative clinical-stage medical dermatology company.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$75.0M
raised

Kairos Pharma is a clinical-stage biopharmaceutical company focused on cancer immunotherapy and drug resistance.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Tarrytown, United States
$7.0M
raised

PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 203 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 203 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked